Your browser doesn't support javascript.
loading
Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically.
Thomas, Anub Mathew; Chaban, Viktoriia; Pischke, Søren E; Orrem, Hilde Lang; Bosnes, Vidar; Sunde, Kjetil; Seljeflot, Ingebjørg; Lundqvist, Christofer; Nakstad, Espen Rostrup; Andersen, Geir Øystein; Schjalm, Camilla; Mollnes, Tom Eirik; Barratt-Due, Andreas.
Affiliation
  • Thomas AM; Department of Immunology, Oslo University Hospital and University of Oslo, Norway; Department of Neurology, Drammen Hospital, Vestre Viken Hospital Trust, Norway.
  • Chaban V; Department of Immunology, Oslo University Hospital and University of Oslo, Norway.
  • Pischke SE; Department of Immunology, Oslo University Hospital and University of Oslo, Norway; Division of Emergencies and Critical Care, Oslo University Hospital, Norway.
  • Orrem HL; Department of Immunology, Oslo University Hospital and University of Oslo, Norway; Division of Emergencies and Critical Care, Oslo University Hospital, Norway.
  • Bosnes V; Department of Immunology, Section of Medical Immunology, Oslo University Hospital, Oslo, Norway.
  • Sunde K; Division of Emergencies and Critical Care, Oslo University Hospital, Norway; Institute of Clinical Medicine, University of Oslo, Norway.
  • Seljeflot I; Institute of Clinical Medicine, University of Oslo, Norway; Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital, Norway; Department of Cardiology, Oslo University Hospital, Norway.
  • Lundqvist C; Institute of Clinical Medicine, University of Oslo, Norway; Department of Neurology, Akershus University Hospital, Oslo, Norway; Health Services Research Unit, Akershus University Hospital, Oslo, Norway.
  • Nakstad ER; Norwegian National Unit for CBRNE Medicine, Division of Medicine, Oslo University Hospital, Norway.
  • Andersen GØ; Department of Cardiology, Oslo University Hospital, Norway.
  • Schjalm C; Department of Immunology, Oslo University Hospital and University of Oslo, Norway.
  • Mollnes TE; Department of Immunology, Oslo University Hospital and University of Oslo, Norway; Research Laboratory, Nordland Hospital, Bodø, Norway; K.G. Jebsen TREC, University of Tromsø, Norway; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.
  • Barratt-Due A; Department of Immunology, Oslo University Hospital and University of Oslo, Norway; Division of Emergencies and Critical Care, Oslo University Hospital, Norway. Electronic address: andreas.barrattdue@gmail.com.
Mol Immunol ; 141: 273-279, 2022 01.
Article in En | MEDLINE | ID: mdl-34906905
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Complement C3 / Complement C5 / Complement C3b / Complement Membrane Attack Complex / Complement Activation Type of study: Diagnostic_studies / Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mol Immunol Year: 2022 Document type: Article Affiliation country: Noruega Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Complement C3 / Complement C5 / Complement C3b / Complement Membrane Attack Complex / Complement Activation Type of study: Diagnostic_studies / Observational_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Mol Immunol Year: 2022 Document type: Article Affiliation country: Noruega Country of publication: Reino Unido